Biopsy, Bone
Percutaneous bone biopsy involves sampling of a representative portion of the bone under imaging guidance. The procedure can be performed as an outpatient basis under local anesthesia without significant discomfort to the patient. The procedure is standard of care for the management of many primary and secondary pathologies of the bone. Commonly used imaging modalities are fluoroscopy, computed tomography (CT), and ultrasound. With advancements in imaging techniques, percutaneous bone biopsy has not only largely replaced open biopsy (surgery) procedures but also enabled the surgeon/radiologist to sample difficult areas of the bone that are not amenable to surgery.
Bone marrow core biopsy is generally performed together with bone marrow aspiration to assess the hematopoietic compartment in a number of neoplastic and non-neoplastic processes involving the hematolymphoid system. It is performed as an outpatient procedure under local anesthesia typically without imaging assistance. Posterior superior iliac crest is the preferred site of aspiration; alternate sites include anterior iliac crest, manubrium of the sternum, tibia (infants), and rarely the vertebral body. In certain clinical scenarios such as metastatic neuroblastoma, bilateral bone marrow aspiration is indicated.
Relative contraindications include coagulopathy, thrombocytopenia, and infection at the site or near the lesion; however, the procedure can be still carried out in these scenarios at the discretion of the operating physician. The procedure is generally well-tolerated. Potential complications include hematoma, bleeding, infection, and injury to the superficial nerves or adjacent organs. Infection and nerve injury are extremely rare at the hands of skilled physician.
- Diagnosis of primary solid bone tumors
- As an aid in diagnosis of bone lesions in solitary myeloma
- As an aid in diagnosis of renal osteodystrophy
- Diagnosis and management of congenital/acquired cytopenias
- Diagnosis and management of hematological neoplasms
- Management of metastatic carcinoma/neuroblastoma
There are no universal reference ranges for bone biopsies or bone marrow core biopsies. In general, a normal bone biopsy shows normal mineralization of bony trabeculae and a 60-80% cellular marrow space consisting of normally maturing hematopoietic cells (granulocytic, erythroid, and megakaryocytic lineages), lymphocytes and plasma cells.
Percutaneous bone biopsies are obtained by a radiologist, usually using ultrasound or CT for guidance. Bone marrow core biopsies are performed by a hematologist or other qualified provider. Routine specimens are placed directly in formalin fixative. Sometimes culture is indicated and tissue for culture should be sent in a sterile container to the laboratory for microbiological assessment. If bone marrow aspiration is also performed, aspirate smears are prepared from bone marrow spicules in the aspirate and stained with Wright-Giemsa for assessment. Additional sample may be submitted in EDTA tubes(refer to bone marrow aspiration section) for flow cytometry, and molecular studies or in heparin for cytogenetic assessment.
- Semin Dial. 2003 Jul-Aug;16(4):341-5, [PMID: 12926408]
- Ann Acad Med Singapore. 2003 Jul;32(4):557-61. [PMID: 12968564]
- Eur Radiol. 1996;6(6):875-81. [PMID: 8972325]
- N Engl J Med 2009;361:e28. [PMID: 19812396]
- Kidney Int Suppl. 1999 Dec;73:S20-5. [PMID: 10633459]